Laurent Levy, CEO, NanaBiotix: NanoXray technology, tiny crystals making a massive difference.




Episode Loading...




PharmaTelevision requires Javascript enabled and Adobe Flash Player to watch our programmes. If you do not have Flash installed, you can download it for free from the Adobe Flash homepage.

Improve your Internet experience and start watching exciting new video content.

Video title: Laurent Levy, CEO, NanaBiotix: NanoXray technology, tiny crystals making a massive difference.
Released on: December 15, 2015. © PharmaVentures Ltd
Visitors: You are watching a 1 minute preview.
Share/save this page:
Email
Bookmark
Facebook
Twitter
LinkedIn
Follow us:
RSS
Twitter
In This Episode:
    Cancer is one of the leading causes of death worldwide and accounted for 7.
  • Summary
  • Transcript
Cancer is one of the leading causes of death worldwide and accounted for 7.6 million deaths (around 13% of all deaths) in 2008. In the Western World and in the U.S. cancer represents the second-leading cause of death after heart attack. Laurent Levy, CEO of NanoBiotix explains to Fintan Walton, CEO of PharmaVentures how they are tackling cancer by developing NanoXray, a pipeline of patented products, which will enhance the radiotherapy efficacy in the tumor without increasing healthy tissues damages.
Full video transcripts are available with PharmaTelevision Premium Content. Click here to buy a subscription or sign up for a 14 day free trial.